Skip to main content
Rural Health Information Hub

Rural Health
News by Topic: Infectious diseases

Mar 25, 2024 - Summarizes recent research finding that female patients at rural Community Health Centers are more likely to be behind on cervical cancer screenings than patients in urban community health centers. Discusses factors associated with the disparity including English proficiency, income levels, employment, and primary care physician access. Notes that the disparity grew during the COVID-19 pandemic.
Source: Medical Xpress
Mar 21, 2024 - The Food and Drug Administration (FDA) has revoked 6 Emergency Use Authorizations issued to Life Technologies Corp.; Bio-Rad Laboratories, Inc.; Revvity, Inc.; bioMérieux SA; and Luminex Corp. related to COVID-19 detection and diagnosis tests.
Source: Federal Register
Mar 19, 2024 - The Substance Abuse and Mental Health Services Administration (SAMHSA) is seeking comments on revisions to the Minority AIDS Initiative (MAI) monitoring tools. Revisions include the inclusion of new cohorts, substantial revisions to the youth and adult questionnaires, updates to the data used to estimate response rates and expected numbers of participants by service duration. Comments are due by May 20, 2024.
Source: Federal Register
Mar 18, 2024 - Highlights recent rural employment statistics released by the Bureau of Labor Statistics. Notes that recent trends were improving, but the latest report showed rural employment has decreased 0.4% when compared to pre-COVID numbers. Includes urban and rural comparisons as well as variations within industries.
Source: The Daily Yonder
Mar 12, 2024 - The U.S. Department of Health and Human Services (HHS) will hold a virtual public meeting of the Presidential Advisory Council on HIV/AIDS (PACHA) on March 27-28, 2024. The agenda and information on how to join the meeting will be posted on the PACHA website prior to the meeting. To provide public comment, pre-registration is required by March 18, 2024.
Source: Federal Register
Mar 11, 2024 - Notice from the Food and Drug Administration (FDA) announcing the revocation of one Emergency Use Authorization (EUA) issued to Eli Lilly and Co. (Lilly) for bamlanivimab and etesevimab administered together. The revocation is effective December 14, 2023.
Source: Federal Register
Mar 5, 2024 - Highlights a mobile health clinic in rural Indiana. Notes the clinic expanded to offer additional services after success offering vaccines during the COVID-19 pandemic.
Source: USDA Rural Development Newsroom
Feb 29, 2024 - The Centers for Disease Control and Prevention (CDC) and Health Resources and Services Administration (HRSA) Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC) will hold a hybrid public meeting on April 9-10, 2024. Agenda items include discussions related to syndemic approach to testing, using prescription data to support the HIV care continuum, HIV and aging, advancing diagnosis of hepatitis C virus infection, updates from the Community Partnerships and Workforce workgroups, and more. Written comments are due by April 19, 2024, and requests to make oral comments should be submitted by March 26, 2024.
Source: Federal Register
Feb 26, 2024 - Summarizes recent research that estimated fungal keratitis in commercially insured patients. Found that the eye infection may be twice as high for rural residents when compared to urban residents in addition to other disparities.
Source: Physician's Weekly
Feb 16, 2024 - The Centers for Disease Control and Prevention (CDC) is allowing an additional 30 days for comments on a proposed information collection project titled "Medical Monitoring Project (MMP)." Information gathered will guide national and local HIV-related service organization and delivery and monitor the receipt of HIV treatment and prevention services and clinical outcomes. Comments are due within 30 days of this notice.
Source: Federal Register